Enhancing pharmacological and behavioural support to reduce smoking relapse: A factorial RCT

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Typically stop smoking services users use a base medicine for 8-12 weeks complemented by counselling, delivered via telephone in Australia. This is effective at helping people stop smoking in the short-term, but after one year most will have relapsed. Effective strategies to prevent smoking relapse are desperately needed. The use of stop smoking medicines beyond 8-12 weeks can help reduce relapse, but research (ours and others), find uptake to be modest. New products that deliver nicotine in va

Funded Activity Details

Start Date: 01-01-2015

End Date: 01-01-2020

Funding Scheme: Targeted Calls

Funding Amount: $939,040.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Medical and Health Sciences

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

There are no Other Keywords available for this funding activity